← Back to Analyst Consensus 
FBRX Hold
Forte Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 28, 2026 | Barclays | downgrade | Overweight → Equal-Weight | — | 53% |
| Jul 21, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Nov 25, 2025 | Evercore ISI Group | initiate | — → Outperform | $65 | 58% |
| Nov 17, 2025 | Chardan Capital | maintain | Buy → Buy | $61 | 46% |
| Aug 18, 2025 | Guggenheim | initiate | — → Buy | $75 | 52% |
| Aug 15, 2025 | Chardan Capital | maintain | Buy → Buy | $61 | 46% |
| Jun 24, 2025 | Chardan Capital | maintain | Buy → Buy | $61 | 46% |
| Apr 1, 2025 | Chardan Capital | maintain | Buy → Buy | $61 | 46% |
| Jan 21, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Dec 4, 2024 | Chardan Capital | maintain | Buy → Buy | $64 | 46% |
| Nov 15, 2024 | Chardan Capital | maintain | Buy → Buy | $64 | 46% |
| Aug 19, 2024 | Chardan Capital | maintain | Buy → Buy | $3 | 46% |
| May 30, 2024 | Brookline Capital | initiate | — → Buy | $4 | 38% |
| Apr 8, 2024 | Ladenburg Thalmann | upgrade | Neutral → Buy | $2.75 | 45% |
| Sep 20, 2021 | Chardan Capital | upgrade | Sell → Neutral | $3.5 | 46% |
| Sep 3, 2021 | Brookline Capital | downgrade | Buy → Hold | $0 | 38% |
| Sep 3, 2021 | Chardan Capital | downgrade | Buy → Sell | $4 | 46% |
| Sep 3, 2021 | Ladenburg Thalmann | downgrade | Buy → Neutral | $0 | 45% |
| Sep 3, 2021 | B. Riley Securities | downgrade | Buy → Neutral | $3 | 54% |
| Sep 3, 2021 | Truist Securities | downgrade | Buy → Hold | $0 | 54% |
| May 14, 2021 | B. Riley Securities | initiate | — → Buy | $73 | 54% |
| Mar 26, 2021 | Citigroup | initiate | — → Buy | $75 | 54% |
| Mar 17, 2021 | Chardan Capital | maintain | — → Buy | $105 | 46% |
| Sep 24, 2020 | Chardan Capital | maintain | — → Buy | $110 | 46% |
| Sep 10, 2020 | Chardan Capital | maintain | — → Buy | $60 | 46% |
| Aug 28, 2020 | Brookline Capital | initiate | — → Buy | $90 | 38% |
| Aug 28, 2020 | Chardan Capital | upgrade | Neutral → Buy | $45 | 46% |
| Aug 25, 2020 | Truist Securities | initiate | — → Buy | $70 | 54% |
| Jun 22, 2020 | Ladenburg Thalmann | initiate | — → Buy | $0 | 45% |
Price Target Trend
May 17, 2026 Oct 27, 2026
EPS Estimates
+1q —
+1y —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days